Rick D.
- Country
- Germany
- Department
- #3206, Klinik fuer Neurologie und Neurophysiologie
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- A Randomized, Double-Blind, Parallel-Group Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension
- A Multi-Center, Double-Blind, Placebo-Controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, A Monoacylglycerol Lipase Inhibitor, as Add-On Therapy to Ocrelizumab, in Participants with Progressive Forms of Multiple Sclerosis
Data & Insights
Has run more than one trial at 82 of 248 partner sites.
Specializations
Neurology and Epilepsy
Rick Dersch is involved in clinical research on focal onset seizures, primary generalized tonic-clonic seizures, refractory epilepsy, and tuberous sclerosis complex-related epilepsy, with additional interest in multiple sclerosis and Parkinson’s disease.
- Seizure disorders
- Multiple sclerosis
- Neurodegenerative disease
His research landscape also includes neuromuscular disease and broader central nervous system conditions.
Autoimmune and Inflammatory Disease
He is active in trials addressing rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Sjögren’s disease, systemic sclerosis, and vasculitis, reflecting a strong focus on immune-mediated disease.
- Rheumatologic disorders
- Connective tissue disease
- Autoinflammatory syndromes
His therapeutic interests also extend to inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
Cardiovascular Medicine
His clinical trial activity includes atrial fibrillation, acute myocardial infarction, coronary artery disease, heart failure, aortic stenosis, and peripheral arterial disease.
- Thromboembolic prevention
- Atherosclerotic disease
- Heart failure
He also contributes to studies in cardiovascular risk reduction and stroke prevention.
Oncology and Hematology
Rick Dersch is involved in research across multiple myeloma, acute myeloid leukemia, myelodysplastic syndromes, lymphoma, breast cancer, lung cancer, and melanoma.
- Myeloid malignancies
- Lymphoid cancers
- Solid tumors
His portfolio also includes transplant-related hematology and graft-versus-host disease.
Metabolic, Pulmonary, and Ophthalmic Disorders
His research interests further cover obesity, type 2 diabetes, lipid disorders, pulmonary fibrosis, sarcoidosis, asthma, and chronic obstructive pulmonary disease.
- Metabolic disease
- Interstitial lung disease
- Retinal disease
He is also engaged in studies on age-related macular degeneration, diabetic and vascular eye disease, and other ophthalmic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.